What is Fiasp?

Fiasp, or insulin aspart, is a rapid-acting insulin analog used to help manage blood sugar levels in adults and children with diabetes mellitus. It is a brand-name prescription insulin.

Fiasp starts working quickly after injection and is used around mealtimes to help manage the rise in blood sugar that can happen after eating. It contains insulin aspart with added ingredients, including niacinamide, which helps the insulin absorb more quickly.

Fiasp should be used only as prescribed by a healthcare provider.

How Does Fiasp (insulin aspart) Work?

Fiasp works like insulin made by the body. Insulin helps move glucose, or sugar, from the blood into muscle and fat cells so it can be used for energy.

After injection, Fiasp helps lower blood sugar by moving glucose into cells and reducing the amount of glucose made by the liver. Because it starts working quickly, it may be used at the start of a meal or within 20 minutes after starting a meal.

Fiasp may help manage post-meal blood sugar levels as part of a diabetes treatment plan.

Fiasp Usage

This medication should be tailored to individual needs, taking into account factors such as metabolic rate, current blood sugar levels, and glycemic control goals. The typical administration routes include subcutaneous injection, continuous subcutaneous infusion using an insulin pump, and intravenous infusion under medical supervision.

  • Subcutaneous Injection: Fiasp should be injected into the abdomen, upper arm, or thigh, either at the start of a meal or within 20 minutes after beginning to eat. Rotating injection sites within the same region is crucial to minimize the risk of developing lipodystrophy (abnormal fat distribution) and localized cutaneous amyloidosis (skin thickening).
  • Continuous Subcutaneous Infusion (Insulin Pump): For patients using an insulin pump, Fiasp is administered continuously in small doses to manage blood sugar levels. It’s essential to follow the manufacturer’s instructions for the insulin pump and rotate the infusion sites regularly within the same region to prevent complications like lipodystrophy.
  • Intravenous Infusion: Fiasp can also be administered intravenously under medical supervision, particularly in hospitals. It must be diluted to 0.5 to 1 unit/mL before use, typically in polypropylene infusion bags.

Dosage adjustments are often necessary when switching from other insulins, altering physical activity levels, changing meal patterns, or during illness. Regular monitoring of blood sugar levels is essential to ensure the dosage remains effective and safe.

Fiasp: Dosage Forms & Strengths

Fiasp is available in several forms to suit different patient needs:

  • 10 mL multiple-dose vial: Ideal for those who prefer using syringes or for use in hospitals.
  • 3 mL single-patient-use Fiasp FlexTouch® pen: This pre-filled pen is a convenient option for patients who need to administer insulin on the go. It is easy to use and helps ensure accurate dosing.
  • 3 mL single-patient-use PenFill® cartridges: Designed for use with PenFill cartridge devices, these cartridges offer flexibility for patients who prefer reusable insulin pens.

Choosing the right form depends on patient preference, lifestyle, and how comfortable they are with the administration method.

Contraindications

Fiasp insulin should not be used in certain situations. It is contraindicated during episodes of hypoglycemia (low blood sugar), as administering Fiasp could worsen the condition, leading to severe complications like seizures or unconsciousness. Additionally, patients who have a known hypersensitivity to insulin aspart (the active ingredient in Fiasp) or any of the other excipients (inactive ingredients) in the formulation should avoid using this insulin, as it could trigger allergic reactions, including potentially life-threatening anaphylaxis.

Warning & Precautions

When using Fiasp insulin, several precautions need to be observed to ensure safety and effectiveness:

  • Risk of Hypoglycemia: Fiasp can cause hypoglycemia, which can be life-threatening if not managed properly. Patients should monitor their blood sugar levels more frequently when their insulin regimen, diet, or physical activity changes. Those with renal or hepatic impairment or hypoglycemia unawareness should be particularly vigilant.
  • Medication Errors: Accidental mix-ups between different insulin types can occur. Patients must check the insulin label carefully before each injection to avoid administration errors.
  • Hypokalemia: Fiasp may cause a drop in potassium levels (hypokalemia), which can be dangerous. Patients at risk should monitor their potassium levels regularly and receive treatment if necessary.
  • Allergic Reactions: Severe allergic reactions, including anaphylaxis, can occur. If a patient experiences symptoms of a serious allergic reaction, Fiasp should be discontinued immediately, and appropriate medical treatment should be administered.
  • Heart Failure: Fiasp, when used with thiazolidinediones (TZDs), may cause fluid retention, leading to or worsening heart failure. Patients should be observed for signs of heart failure, and treatment may need to be adjusted or discontinued if symptoms develop.
  • Insulin Pump Malfunction: An insulin pump malfunction can result in hyperglycemia or ketoacidosis. Patients using Fiasp with an insulin pump should monitor their glucose levels closely and be prepared to administer Fiasp by subcutaneous injection if needed.

Before taking this medication, speak to a healthcare practitioner about any current medical conditions. They should also provide information on managing your blood sugar levels.  

You should not take Fiasp Insulin if:  

  • You have an allergy to any of its ingredients.
  • Your blood sugar levels are too low (hypoglycemia).  
  • Are pregnant, breastfeeding, or planning to become pregnant.
  • It has been documented that Fiasp can pass through breast milk. 
  • Are currently taking any prescription medications or over-the-counter medicines (this may also include supplements).
  • Have kidney or liver problems

Side Effects

Common side effects associated with Fiasp insulin include:

  • Hypoglycemia: This is the most common side effect and can range from mild to severe.
  • Allergic Reactions and Hypersensitivity: These can include rashes, itching, and in rare cases, anaphylaxis.
  • Injection/Infusion Site Reactions: Redness, swelling, or itching at the injection or infusion site.
  • Lipodystrophy: Abnormal distribution of fat at the injection site, which can be avoided by rotating injection sites.
  • Weight Gain: Some patients may experience weight gain as a side effect of insulin therapy.

Potential Drug Interactions

Several drugs can interact with Fiasp insulin, potentially altering its effectiveness:

  • Drugs that Increase Hypoglycemia Risk: Medications such as oral antidiabetics, beta-blockers, and alcohol can increase the risk of hypoglycemia when taken with Fiasp. Dosage adjustments and close monitoring of blood sugar levels are necessary.
  • Drugs that Blunt Hypoglycemia Signs: Medications like beta-blockers, clonidine, and guanethidine may mask the symptoms of hypoglycemia, making it harder for patients to recognize a low blood sugar event. This necessitates more frequent blood glucose monitoring.
  • Drugs that Increase or Decrease the Blood Glucose-Lowering Effect: Some drugs may either enhance or reduce Fiasp’s blood glucose-lowering effect, requiring careful monitoring and possible dose adjustments.

Insulin Storage

Proper storage of Fiasp insulin is crucial to maintain its efficacy:

  • Unopened Vials, Pens, and Cartridges: Store in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze. Protect from light.
  • In-Use Vials, Pens, and Cartridges: Once in use, Fiasp can be stored at room temperature, below 86°F (30°C), and should be used within 28 days. Do not return in-use products to the refrigerator.
  • Avoid Extreme Temperatures: Never expose Fiasp to direct heat or sunlight, and avoid storing it in a car or other areas where temperatures may fluctuate.

Ordering Information

Prescription Information

Fiasp is a prescription medication.

A valid prescription from a licensed healthcare provider is required before Fiasp can be dispensed.

Prescription orders are reviewed according to pharmacy processing requirements before fulfillment.

Pricing Information

Pricing may vary depending on quantity, product availability, pharmacy source, and shipping destination.

Eligible first-time customers may use coupon code FIRST10 during checkout.

Customers may review current pricing during checkout before placing an order.

Shipping Information

Orders are processed after prescription review requirements have been completed.

Shipping timelines may vary depending on product availability, pharmacy source, destination, and carrier service levels.

Tracking information may be available depending on the shipping method selected.

Fiasp is a temperature-sensitive medication.

Special packaging may be used to help maintain recommended storage conditions during transit.

Upon delivery, inspect the shipment and store the medication according to the product storage instructions.

Avoid exposing insulin products to extreme heat or freezing temperatures.

Customer Support Information

Phone: 1-888-525-1815

Fax: 1-888-234-1275

Email: info@buycanadianinsulin.com

Customer support is available for questions related to prescription submission, order processing, product availability, and shipping information.

Frequently Asked Questions

Fiasp (insulin aspart) is fast-acting mealtime insulin for adults and children with diabetes to help better manage blood sugar levels.

Fiasp is a fast-acting insulin that is closely related to human insulin.

Dosage varies from person-to-person and is based on a number of factors such as weight. Initial dosage instructions should be determined in collaboration with your doctor.

You and your doctor can work together to create a schedule that makes sense for you. Fiasp is recommended to be taken at mealtime, either at the start of a meal or 20 minutes after. It is best not to skip meals or postpone eating while taking Fiasp.

Yes, Fiasp can be used in a Tandem insulin pump. However, it is important to follow the specific instructions provided by the insulin pump manufacturer to ensure proper use and avoid complications.

Yes, Fiasp is a fast-acting insulin. It begins to work within 2.5 minutes of injection, making it one of the quickest options for managing blood sugar spikes after meals.

Fiasp insulin pens are designed for single use and cannot be refilled. Once the insulin in the pen is depleted, you should dispose of the pen according to local regulations and begin using a new one.

Due to its rapid onset of action, Fiasp is considered a good insulin option for managing post-meal blood sugar levels. It provides flexibility in timing and is effective in controlling blood glucose spikes.

Yes, Fiasp is approved for use in insulin pumps. It can be administered via continuous subcutaneous infusion, but following the pump manufacturer’s guidelines is important.

The cost of a vial of Fiasp insulin can vary depending on the location and pharmacy, but it typically ranges from $300 to $400 for a 10 mL vial in the United States. However, you have the option to buy Fiasp insulin from BuyCanadianInsulin.com at a reduced cost of $58 for 1 vial and $119 for 5 pens.

Fiasp can be combined with intermediate- or long-acting insulins to provide comprehensive blood glucose management throughout the day.

If you miss a dose of Fiasp, take it as soon as you remember, provided it’s still within 20 minutes after starting your meal. If more time has passed, skip the missed dose and proceed with your next scheduled dose.

Fiasp should not be mixed with other insulins in the same syringe or insulin pump reservoir, as mixing could alter its effectiveness.

Yes, unopened Fiasp should be stored in the refrigerator. Once opened, it can be kept at room temperature for up to 28 days.

Yes, like other insulins, Fiasp can cause weight gain as a side effect, especially if blood sugar levels are consistently well-controlled.

Yes, Fiasp is approved for use in both adult and pediatric patients with diabetes mellitus.

If Fiasp insulin freezes, it should not be used. Frozen insulin may lose its effectiveness and could potentially harm the patient.

When stored properly in the refrigerator, Fiasp insulin typically lasts 24 months. Once opened, it should be used within 28 days.

Yes, Fiasp insulin requires a prescription from a healthcare professional.

Yes, you can exercise after taking Fiasp, but physical activity can lower blood glucose levels. Monitoring your blood sugar before and after exercising is important to avoid hypoglycemia.

Disclaimer

Buy Canadian Insulin provides educational information about medications and health conditions for informational purposes only. This content is not intended to replace professional medical advice, diagnosis, or treatment. Prescription medications require a valid prescription review and processing through participating pharmacy partners. Product availability, pricing, and shipping timelines may vary. Consult your healthcare provider or pharmacist before starting, stopping, or changing any medication.